Maxcyte (MXCT) Other Gross PP&E Adjustments (2019 - 2025)
Maxcyte (MXCT) has disclosed Other Gross PP&E Adjustments for 6 consecutive years, with -$10.1 million as the latest value for Q3 2025.
- On a quarterly basis, Other Gross PP&E Adjustments fell 364.16% to -$10.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$10.1 million, a 364.16% decrease, with the full-year FY2024 number at -$6.6 million, up 63.4% from a year prior.
- Other Gross PP&E Adjustments was -$10.1 million for Q3 2025 at Maxcyte, down from -$9.4 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $3.8 million in Q3 2024 to a low of -$18.0 million in Q4 2023.
- A 5-year average of -$5.0 million and a median of -$6.6 million in 2024 define the central range for Other Gross PP&E Adjustments.
- Peak YoY movement for Other Gross PP&E Adjustments: crashed 8310.96% in 2021, then soared 166.84% in 2024.
- Maxcyte's Other Gross PP&E Adjustments stood at -$6.7 million in 2021, then skyrocketed by 80.63% to -$1.3 million in 2022, then plummeted by 1275.04% to -$18.0 million in 2023, then surged by 63.4% to -$6.6 million in 2024, then tumbled by 54.28% to -$10.1 million in 2025.
- Per Business Quant, the three most recent readings for MXCT's Other Gross PP&E Adjustments are -$10.1 million (Q3 2025), -$9.4 million (Q2 2025), and -$6.9 million (Q1 2025).